MV-NIS through cell carriers (Vyriad)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMV-NIS through cell carriers (Vyriad)
Drug Alias NameOncolytic measles virus therapy expressing NIS (Vyriad)MV-NIS in combination with cell carriers (Vyriad)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsHematologic NeoplasmsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVyriad
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVyriad
Active IndicationsN/A
Inactive IndicationsHematologic NeoplasmsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A